Vaccine innovations for emerging infectious diseases—a symposium report

Jennifer Cable, Padmini Srikantiah, James E. Crowe, Bali Pulendran, Adrian Hill, Ann Ginsberg, Wayne Koff, Anuja Mathew, Tony Ng, Kathrin Jansen, Gregory Glenn, Sallie Permar, Ian Wilson, David B. Weiner, Drew Weissman, Rino Rappuoli

Research output: Contribution to journalComment/debatepeer-review

10 Scopus citations


Vaccines have been incredibly successful at stemming the morbidity and mortality of infectious diseases worldwide. However, there are still no effective vaccines for many serious and potentially preventable infectious diseases. Advances in vaccine technology, including new delivery methods and adjuvants, as well as progress in systems biology and an increased understanding of the human immune system, hold the potential to address these issues. In addition, maternal immunization has opened an avenue to address infectious diseases in neonates and very young infants. This report summarizes the presentations from a 1-day symposium at the New York Academy of Sciences entitled “Innovative Vaccines against Resistant Infectious Diseases and Emerging Threats,” held on May 20, 2019.

Original languageEnglish (US)
Pages (from-to)14-26
Number of pages13
JournalAnnals of the New York Academy of Sciences
Issue number1
StatePublished - 2020


  • CMV
  • DNA vaccine
  • Ebola
  • HIV
  • MERS
  • RNA vaccine
  • RSV
  • Zika
  • antimicrobial resistance
  • infectious disease
  • influenza
  • malaria
  • maternal immunization
  • monoclonal antibodies
  • systems vaccinology
  • tuberculosis
  • vaccine
  • vaccinology

ASJC Scopus subject areas

  • Neuroscience(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • History and Philosophy of Science


Dive into the research topics of 'Vaccine innovations for emerging infectious diseases—a symposium report'. Together they form a unique fingerprint.

Cite this